New Strong Sell Stocks for March 18th

Group 1 - ACNB operates as a provider of banking and financial services to individuals and businesses, with a Zacks Consensus Estimate for its current year earnings revised almost 13.5% downward over the last 60 days [1] - Amphastar Pharmaceuticals focuses on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products, with a Zacks Consensus Estimate for its current year earnings revised 3.4% downward over the last 60 days [1] - Entrada Therapeutics aims to transform patient lives by establishing a new class of medicines, Endosomal Escape Vehicles(TM), with a Zacks Consensus Estimate for its current year earnings revised 7.9% downward over the last 60 days [1]